MedPath

To evaluate the effect of Sweet Almond and Plantago seed, on Proteinuria in patients with Diabetic Nephropathy.

Not Applicable
Recruiting
Conditions
Proteinuria in Diabetic Nephropathy.
Other specified diabetes mellitus with diabetic polyneuropathy
E13.42
Registration Number
IRCT20221015056179N1
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Informed consent to enter the project
People aged 30 to 70 years
No kidney failure or any other disease that leads to diabetic nephropathy
No symptoms of urinary tract infection during study
Not taking anticoagulants, corticosteroids
Excretion of albumin between 30-300 mg in 24-hour urine
Blood pressure less than 160 mmHg
Potassium less than 5.8 mA/L
GFR more than 60 ml per minute per 1.73 m3 body
Creatinine less than 2 mg/dl
No professional athletes
Not having Chronic neurological disease (severe depression and anxiety)
Non-pregnancy and lactation
SGPT rate less than three times normal before study (below 100 units per liter)
HbA1C between 7 and 9%
No urinary tract infection and kidney ducts.

Exclusion Criteria

Causing any complications
Dissatisfaction with follow-up treatment
Increase proteinuria
Drug allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decreased Proteinuria in urine. Timepoint: At the beginning of the study (before the intervention) and on days 30 after the intervention. Method of measurement: UA Urinary Protein.;Decreased Proteinuria in 24 hour Urinary protein. Timepoint: At the beginning of the study (before the intervention) and on day 60 after the intervention. Method of measurement: 24 hour Urinary Protein.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath